Projected Target Price for VLU Analyst: $223
ETF Target Price Analysis: The SPDR S&P 1500 Value Tilt ETF (VLU) has an implied analyst target price of $223.30, indicating a potential upside of 10.40% from its current trading price of $202.27.
Notable Holdings with Upside: Key underlying holdings of VLU, such as Extreme Networks Inc (EXTR), Sanmina Corp (SANM), and Travel + Leisure Co (TNL), show significant upside potential based on analyst target prices, with expected increases of 11.98%, 11.66%, and 11.08% respectively.
Trade with 70% Backtested Accuracy
Analyst Views on SANM
About SANM
About the author

- Valuation Tool Comparison: While the price-to-earnings (P/E) ratio is popular among investors, the EV-to-EBITDA ratio is considered superior due to its comprehensive valuation approach, particularly in assessing potential acquisition targets, as it better reflects a company's true value and earnings potential.
- Industry Performance Variance: The EV-to-EBITDA ratio varies significantly across industries, with high-growth sectors typically exhibiting higher multiples, thus caution is advised when making cross-industry comparisons to avoid misleading investment decisions.
- Company Growth Expectations: Eni S.p.A. anticipates a year-over-year growth rate of 10.3% for 2026, while Sanmina Corp. boasts an impressive expected growth rate of 66.5%, and FirstSun Capital Bancorp and First American Financial Corp. project growth rates of 13.8% and 5%, respectively, indicating strong future profitability potential for these firms.
- Investment Strategy Recommendation: Investors are advised to combine EV-to-EBITDA with other major valuation ratios such as price-to-book (P/B) and price-to-sales (P/S) to comprehensively screen for value stocks, thereby enhancing the likelihood of investment success.

Market Opening: U.S. stock markets are set to open in two hours.
Evolution Metals & Technologies Corp. Performance: EMAT saw a significant increase of 21.9% in pre-market trading.
Keysight Technologies Inc. Performance: KEYS experienced a rise of 15.2% in pre-market trading.
Overall Market Sentiment: The pre-market gains indicate positive investor sentiment ahead of the market opening.
- Strong Earnings: Sanmina reported nearly $3.19 billion in net sales for Q1 FY2026, a significant increase from just over $2 billion last year, highlighting the company's robust growth potential in the AI market.
- Profit Growth: The company’s non-GAAP net income exceeded $132 million ($2.38 per share), surpassing analyst expectations of $2.14 per share, indicating improved profitability.
- Negative Market Reaction: Despite beating estimates, investors reacted negatively to the company's weak guidance, resulting in a nearly 22% drop in stock price, reflecting a disconnect between high market expectations and actual performance.
- Cautious Outlook: Sanmina projects Q2 net sales between $3.1 billion and $3.4 billion; although the adjusted EPS forecast exceeds the average analyst estimate, the market's expectation for higher sales figures indicates investor concerns about future performance.
- S&P 500 Hits All-Time High: The S&P 500 index rose 0.41% on Tuesday, achieving a new all-time high, reflecting strong market confidence in tech stocks and chipmakers, particularly after Micron Technology announced a $24 billion investment in Singapore to expand memory chip capacity.
- Nasdaq Performance Strong: The Nasdaq 100 index increased by 0.88%, reaching a 2.75-month high, indicating investor optimism in AI infrastructure and semiconductor sectors, which propelled the broader market higher.
- Consumer Confidence Index Declines: Despite the stock market gains, the US January consumer confidence index unexpectedly fell to an 11.5-year low of 84.5, highlighting economic uncertainty that could negatively impact future consumer spending.
- Health Insurance Stocks Under Pressure: The proposal by the US government to keep payments to private Medicare plans flat next year led to a broad decline in health insurance stocks, with UnitedHealth Group forecasting a revenue contraction in 2026, marking the first annual decline in over 30 years, raising further market concerns.
- Tech Stock Surge: The Nasdaq 100 index rose by 0.87%, reaching a 2.75-month high, primarily driven by strength in chipmakers and AI infrastructure stocks, indicating strong market confidence in the tech sector.
- Micron's Investment Plan: Micron Technology announced a $24 billion investment in Singapore to expand memory chip capacity, leading to a 5% stock price increase, which not only enhances its competitive position but may also stimulate growth in the related supply chain.
- Consumer Confidence Decline: Despite the stock market gains, the US January consumer confidence index unexpectedly fell to an 11.5-year low of 84.5, indicating economic uncertainty that could negatively impact consumer spending.
- Health Insurance Stocks Under Pressure: The proposed flat payments for private Medicare plans led UnitedHealth Group's stock to drop over 19%, marking the first expected revenue decline in over 30 years, reflecting the policy risks facing the healthcare sector.
- Amazon's Strategic Shift: Amazon's decision to close its Fresh and Go brick-and-mortar stores marks a significant pivot in its grocery strategy, resulting in a more than 1% rise in its stock during midday trading, while rivals Kroger and Albertsons saw declines of about 3%.
- Micron's Expansion Investment: Micron Technology has commenced construction of an advanced wafer fabrication facility at its existing NAND manufacturing plant in Singapore, with a planned investment of approximately $24 billion over the next decade, leading to a roughly 5% increase in its stock price.
- Sysco's Earnings Beat: Sysco reported earnings that exceeded expectations, with a fiscal second-quarter EPS of $0.99 compared to the $0.98 anticipated by analysts, resulting in a 9% stock price increase and an updated full-year guidance at the higher end of $4.50 to $4.60 per share.
- UnitedHealth Stock Decline: Shares of UnitedHealth and Humana dropped about 20% after the Centers for Medicare & Medicaid Services proposed a mere 0.09% increase in 2027 Medicare Advantage payment rates, significantly lower than the expected 4% to 6% rise.









